Clinical Trials Directory

Trials / Conditions / Metastatic Gastrointestinal Carcinoid Tumor

Metastatic Gastrointestinal Carcinoid Tumor

14 registered clinical trials studyying Metastatic Gastrointestinal Carcinoid Tumor — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingEMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
NCT05176665
Shanghai EpimAb Biotherapeutics Co., Ltd.Phase 1 / Phase 2
WithdrawnISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With
NCT04602117
QuantumLeap Healthcare CollaborativePhase 1
CompletedRegorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
NCT02259725
University of Southern CaliforniaPhase 2
CompletedTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT01155258
University of Southern CaliforniaPhase 1
CompletedErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Nec
NCT00397384
National Cancer Institute (NCI)Phase 1
CompletedSorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
NCT00131911
National Cancer Institute (NCI)Phase 2
CompletedEverolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
NCT00655655
Mayo ClinicPhase 1
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
TerminatedRomidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT00084461
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
NCT00075439
National Cancer Institute (NCI)Phase 2
CompletedTemsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma
NCT00093782
National Cancer Institute (NCI)Phase 2
CompletedBevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
NCT00055809
National Cancer Institute (NCI)Phase 2
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1